Patent Assignment
Reel/Frame 044695/0001
Assignment of Assignor's Interest
Recorded: 2018-01-23
Pages: 14
Assignors
COSSROW, JENNIFER
Executed: 2008-07-07
RAIMUNDO, BRIAN C.
Executed: 2008-07-08
TANAKA, HIROKO
Executed: 2008-07-08
Assignee
SUNESIS PHARMACEUTICALS, INC.
341 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
Substituted Pyrimidines for Inhibiting Raf Kinase Activity
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 23, 2018
From: CHEN, WEIRONG; FRANKLIN, LLOYD; GUAN, BING; JONES, JOHN HOWARD
To: BIOGEN IDEC MA INC.
Reel/Frame 044694/0982 →
Assignment of Assignor's Interest
Jan 23, 2018
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 044695/0020 →
Assignment of Assignor's Interest
Jan 14, 2021
From: MILLENNIUM PHARMACEUTICALS, INC.
To: DOT THERAPEUTICS-1, INC.
Reel/Frame 054921/0546 →
Merger
May 17, 2022
From: DOT THERAPEUTICS-2, INC.; DOT THERAPEUTICS-1, INC.
To: DAY ONE BIOPHARMACEUTICALS, INC.
Reel/Frame 059936/0096 →
Change of Name
Apr 14, 2023
From: SUNESIS PHARMACEUTICALS, INC.
To: VIRACTA THERAPEUTICS, INC.
Reel/Frame 063349/0100 →
Assignment of Assignor's Interest
Dec 3, 2024
From: VIRACTA THERAPEUTICS, INC.
To: XOMA (US) LLC
Reel/Frame 069474/0049 →
Security Interest
Jul 14, 2026
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; XOMA (US) LLC
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075969/0966 →